268 related articles for article (PubMed ID: 19328787)
1. Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.
Gaur U; Showalter M; Hickerson S; Dalvi R; Turco SJ; Wilson ME; Beverley SM
Exp Parasitol; 2009 Jul; 122(3):182-91. PubMed ID: 19328787
[TBL] [Abstract][Full Text] [Related]
2. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
[TBL] [Abstract][Full Text] [Related]
3. An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.
Goyard S; Segawa H; Gordon J; Showalter M; Duncan R; Turco SJ; Beverley SM
Mol Biochem Parasitol; 2003 Aug; 130(1):31-42. PubMed ID: 14550894
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.
Capul AA; Hickerson S; Barron T; Turco SJ; Beverley SM
Infect Immun; 2007 Sep; 75(9):4629-37. PubMed ID: 17606605
[TBL] [Abstract][Full Text] [Related]
5. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters.
Ma D; Russell DG; Beverley SM; Turco SJ
J Biol Chem; 1997 Feb; 272(6):3799-805. PubMed ID: 9013638
[TBL] [Abstract][Full Text] [Related]
6. The role of phosphoglycans in Leishmania-sand fly interactions.
Sacks DL; Modi G; Rowton E; Späth G; Epstein L; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):406-11. PubMed ID: 10618431
[TBL] [Abstract][Full Text] [Related]
7. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.
Zhang WW; Matlashewski G
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059
[TBL] [Abstract][Full Text] [Related]
8. Persistence without pathology in phosphoglycan-deficient Leishmania major.
Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
[TBL] [Abstract][Full Text] [Related]
9.
Jesus-Santos FH; Lobo-Silva J; Ramos PIP; Descoteaux A; Lima JB; Borges VM; Farias LP
Front Cell Infect Microbiol; 2020; 10():408. PubMed ID: 32903718
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes.
Matte C; Arango Duque G; Descoteaux A
Infect Immun; 2021 Jun; 89(7):e0000921. PubMed ID: 33875473
[TBL] [Abstract][Full Text] [Related]
11. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.
Dermine JF; Scianimanico S; Privé C; Descoteaux A; Desjardins M
Cell Microbiol; 2000 Apr; 2(2):115-26. PubMed ID: 11207568
[TBL] [Abstract][Full Text] [Related]
12. The Leishmania GDP-mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits.
Hong K; Ma D; Beverley SM; Turco SJ
Biochemistry; 2000 Feb; 39(8):2013-22. PubMed ID: 10684651
[TBL] [Abstract][Full Text] [Related]
13. Leishmania virulence: it's a knock out!
Handman E
Trends Parasitol; 2001 Feb; 17(2):60. PubMed ID: 11228002
[No Abstract] [Full Text] [Related]
14. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
Mukhopadhyay S; Sen P; Majumder HK; Roy S
J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
[TBL] [Abstract][Full Text] [Related]
15. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani.
Tolson DL; Turco SJ; Pearson TW
Infect Immun; 1990 Nov; 58(11):3500-7. PubMed ID: 1699895
[TBL] [Abstract][Full Text] [Related]
16. Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.
Wang Y; Chen Y; Xin L; Beverley SM; Carlsen ED; Popov V; Chang KP; Wang M; Soong L
Infect Immun; 2011 Mar; 79(3):1124-33. PubMed ID: 21189319
[TBL] [Abstract][Full Text] [Related]
17. Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes.
Scianimanico S; Desrosiers M; Dermine JF; Méresse S; Descoteaux A; Desjardins M
Cell Microbiol; 1999 Jul; 1(1):19-32. PubMed ID: 11207538
[TBL] [Abstract][Full Text] [Related]
18. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
[TBL] [Abstract][Full Text] [Related]
19. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
20. A specialized pathway affecting virulence glycoconjugates of Leishmania.
Descoteaux A; Luo Y; Turco SJ; Beverley SM
Science; 1995 Sep; 269(5232):1869-72. PubMed ID: 7569927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
